Yang Chao, Zhang Chi, Cao Yongsheng, Deng Qi-Fei, Mao Changkun
Department of Urology, Anhui Provincial Children's Hospital, Hefei, China.
Department of Oncology, Anhui Chest Hospital, Hefei, Anhui, China.
Front Pediatr. 2025 Jan 6;12:1470948. doi: 10.3389/fped.2024.1470948. eCollection 2024.
This study evaluates the efficacy and safety of robot-assisted laparoscopic ipsilateral ureteroureterostomy (RAL-IUU) in treating children with duplex kidney ureteral malformations by detailing our early single-center experience.
We conducted a retrospective analysis of clinical data from 14 children with complete duplex kidney ureteral malformations treated with RAL-IUU at our institution from December 2021 to January 2024. Clinical data included patient demographics, surgical details, and postoperative outcomes.
The operation time averaged 128.71 ± 22.35 min in 14 cases, intraoperative blood loss was 7.57 ± 2.77 ml, drainage tube placement lasted for 3.14 ± 0.66 days, and hospital stay averaged 4.79 ± 0.70 days. Stent placement lasted 43.58 ± 6.33 days. Notable changes were observed in the upper moiety anterior-posterior diameter (APD) before and after surgery (23.84 ± 8.05 mm vs. 6.71 ± 2.20 mm, < 0.001), diameter at the widest part of the upper moiety ureter (15.58 ± 6.07 mm vs. 4.61 ± 0.78 mm, < 0.001), and split renal function of the upper moiety (12.28 ± 3.04% vs. 16.50 ± 2.75%, < 0.001). Postoperative follow-up ranged from 6 to 18 months; during the period with a D-J stent, one case developed a urinary tract infection, one case had recurrent gross hematuria, and another child exhibited significant urinary irritative symptoms (frequency), with an abdominal plain film revealing that the D-J tube had descended completely into the bladder, and symptoms disappeared after the removal of the D-J tube. During the follow-up period post-D-J tube removal, none of the 14 children experienced a urinary tract infection again during the follow up period, urinary incontinence ceased.
RAL-IUU provides an excellent surgical field and operating space, precise suturing, and minimal surgical trauma. Postoperatively, there is a reduction in renal pelvis and ureteral hydronephrosis, recovery of split renal function, and minimal complications all with rapid recovery. RAL-IUU is a safe and feasible treatment option for children with complete duplex kidneys.
本研究通过详细介绍我们早期的单中心经验,评估机器人辅助腹腔镜同侧输尿管输尿管吻合术(RAL-IUU)治疗重复肾输尿管畸形患儿的疗效和安全性。
我们对2021年12月至2024年1月在本机构接受RAL-IUU治疗的14例完全性重复肾输尿管畸形患儿的临床资料进行了回顾性分析。临床资料包括患者人口统计学、手术细节和术后结果。
14例手术平均时间为128.71±22.35分钟,术中出血量为7.57±2.77毫升,引流管留置时间为3.14±0.66天,平均住院时间为4.79±0.70天。支架留置时间为43.58±6.33天。手术前后上半肾前后径(APD)(23.84±8.05毫米对6.71±2.20毫米,<0.001)、上半肾输尿管最宽处直径(15.58±6.07毫米对4.61±0.78毫米,<0.001)以及上半肾分肾功能(12.28±3.04%对16.50±2.75%,<0.001)均有显著变化。术后随访6至18个月;在留置D-J支架期间,1例发生尿路感染,1例反复出现肉眼血尿,另1例患儿出现明显的尿路刺激症状(尿频),腹部平片显示D-J管已完全落入膀胱,拔除D-J管后症状消失。在拔除D-J管后的随访期间,14例患儿在随访期间均未再次发生尿路感染,尿失禁停止。
RAL-IUU提供了良好的手术视野和操作空间,缝合精确,手术创伤小。术后肾盂和输尿管积水减轻,分肾功能恢复,并发症少,恢复快。RAL-IUU是治疗完全性重复肾患儿的一种安全可行的治疗选择。